Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. The visible addition indicates access to the study record is blocked, while site chrome remains, signaling a restricted access state.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the page. This reflects a minor software version update and does not alter the study content or eligibility details.SummaryDifference0.1%

- Check30 days agoChange DetectedA new NIH grant/contract entry was added to the study's identifiers, signaling NIH funding for the trial.SummaryDifference0.1%

- Check44 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5, signaling a new page/system version without altering the displayed content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.6.4 is now shown in the footer, replacing v3.6.3, indicating a small deployment update to the page.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous page version and indicating a minor administrative update to the page.SummaryDifference0.1%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.